Myeloproliferative neoplasm stem cells von Mead, Adam J., Mullally, Ann

Volltext

Biology and therapeutic targeting of molecular mechanisms in MPNs von How, Joan, Garcia, Jacqueline S., Mullally, Ann

Volltext

Mutant calreticulin in myeloproliferative neoplasms von How, Joan, Hobbs, Gabriela S., Mullally, Ann

Volltext

Remodeling the Bone Marrow Microenvironment - A Proposal for Targeting Pro-inflammatory Contributors in MPN von Jutzi, Jonas Samuel, Mullally, Ann

Volltext

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms von Wolach, O, Sellar, RS, Martinod, K, Cherpokova, D, McConkey, M, Chappell, RJ, Silver, AJ, Adams, D, Castellano, CA, Schneider, RK, Padera, RF, DeAngelo, DJ, Wadleigh, M, Steensma, DP, Galinsky, I, Stone, RM, Genovese, G, McCarroll, SA, Iliadou, B, Hultman, C, Neuberg, D, Mullally, A, Wagner, DD, Ebert, BL

Volltext

Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms von Van Egeren, Debra, Escabi, Javier, Nguyen, Maximilian, Liu, Shichen, Reilly, Christopher R., Patel, Sachin, Kamaz, Baransel, Kalyva, Maria, DeAngelo, Daniel J., Galinsky, Ilene, Wadleigh, Martha, Winer, Eric S., Luskin, Marlise R., Stone, Richard M., Garcia, Jacqueline S., Hobbs, Gabriela S., Camargo, Fernando D., Michor, Franziska, Mullally, Ann, Cortes-Ciriano, Isidro, Hormoz, Sahand

Volltext

Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells von Dutt, Shilpee, Narla, Anupama, Lin, Katherine, Mullally, Ann, Abayasekara, Nirmalee, Megerdichian, Christine, Wilson, Frederick H., Currie, Treeve, Khanna-Gupta, Arati, Berliner, Nancy, Kutok, Jeffery L., Ebert, Benjamin L.

Volltext

Busy signal: platelet-derived growth factor activation in myelofibrosis von Marneth, Anna E., Mullally, Ann

Volltext

Defining the requirements for the pathogenic interaction between mutant calreticulin and MPL in MPN von Elf, Shannon, Abdelfattah, Nouran S., Baral, April J., Beeson, Danielle, Rivera, Jeanne F., Ko, Amy, Florescu, Natalie, Birrane, Gabriel, Chen, Edwin, Mullally, Ann

Volltext

Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation von Elf, Shannon, Abdelfattah, Nouran S, Chen, Edwin, Perales-Patón, Javier, Rosen, Emily A, Ko, Amy, Peisker, Fabian, Florescu, Natalie, Giannini, Silvia, Wolach, Ofir, Morgan, Elizabeth A, Tothova, Zuzana, Losman, Julie-Aurore, Schneider, Rebekka K, Al-Shahrour, Fatima, Mullally, Ann

Volltext

Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy von Koppikar, Priya, Bhagwat, Neha, Kilpivaara, Outi, Manshouri, Taghi, Adli, Mazhar, Hricik, Todd, Liu, Fan, Saunders, Lindsay M., Mullally, Ann, Abdel-Wahab, Omar, Leung, Laura, Weinstein, Abby, Marubayashi, Sachie, Goel, Aviva, Gönen, Mithat, Estrov, Zeev, Ebert, Benjamin L., Chiosis, Gabriela, Nimer, Stephen D., Bernstein, Bradley E., Verstovsek, Srdan, Levine, Ross L.

Volltext

Role of Casein Kinase 1A1 in the Biology and Targeted Therapy of del(5q) MDS von Schneider, Rebekka K., Ademà, Vera, Heckl, Dirk, Järås, Marcus, Mallo, Mar, Lord, Allegra M., Chu, Lisa P., McConkey, Marie E., Kramann, Rafael, Mullally, Ann, Bejar, Rafael, Solé, Francesc, Ebert, Benjamin L.

Volltext

Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition von Jeremy Wen, Qiang, Yang, Qiong, Goldenson, Benjamin, Malinge, Sébastien, Lasho, Terra, Schneider, Rebekka K, Breyfogle, Lawrence J, Schultz, Rachael, Gilles, Laure, Koppikar, Priya, Abdel-Wahab, Omar, Pardanani, Animesh, Stein, Brady, Gurbuxani, Sandeep, Mullally, Ann, Levine, Ross L, Tefferi, Ayalew, Crispino, John D

Volltext

Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation von Mullally, Ann, Ritz, Jerome

Volltext

Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms von Chen, Edwin, Schneider, Rebekka K., Breyfogle, Lawrence J., Rosen, Emily A., Poveromo, Luke, Elf, Shannon, Ko, Amy, Brumme, Kristina, Levine, Ross, Ebert, Benjamin L., Mullally, Ann

Volltext

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies von Abdel-Wahab, Omar, Mullally, Ann, Hedvat, Cyrus, Garcia-Manero, Guillermo, Patel, Jay, Wadleigh, Martha, Malinge, Sebastien, Yao, JinJuan, Kilpivaara, Outi, Bhat, Rukhmi, Huberman, Kety, Thomas, Sabrena, Dolgalev, Igor, Heguy, Adriana, Paietta, Elisabeth, Le Beau, Michelle M., Beran, Miloslav, Tallman, Martin S., Ebert, Benjamin L., Kantarjian, Hagop M., Stone, Richard M., Gilliland, D. Gary, Crispino, John D., Levine, Ross L.

Volltext

Both sides now: losses and gains of mutant CALR von Mullally, Ann

Volltext

Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms von Takei, Hisashi, Coelho‐Silva, Juan Luiz, Tavares Leal, Cristina, Queiroz Arantes Rocha, Adriana, Mantello Bianco, Thiago, Welner, Robert S., Mishima, Yuta, Kobayashi, Ikei S., Mullally, Ann, Lima, Keli, Machado‐Neto, João Agostinho, Kobayashi, Susumu S., Lobo de Figueiredo‐Pontes, Lorena

Volltext

1021 – BIOLOGY AND THERAPEUTIC TARGETING OF MUTANT CALRETICULIN INDUCED MPN von Mullally, Ann

Volltext

Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera von Mullally, Ann, Poveromo, Luke, Schneider, Rebekka K., Al-Shahrour, Fatima, Lane, Steven W., Ebert, Benjamin L.

Volltext